WHO naming stem · suffix · 831 listed names
-mab
monoclonal antibodies (previous naming scheme)
Where it sits in a name
WHO writes the stem as -mab. So the letters mab sit at the end of the name (…mab).
All 831 names WHO lists under -mab
These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.
- abrezekimab
- acapatamab
- acasunlimab
- acrixolimab
- adabrelimab
- adalimumab
- adalimumab beta
- adalimumab fosimdesonide
- alemtuzumab
- alemtuzumab beta
- alnuctamab
- alomfilimab
- alsevalimab
- altumomab
- amlitelimab
- amubarvimab
- anatumomab mafenatox
- anbenitamab
- anetumab corixetanglo
- anetumab ravtansine
- anifrolumab
- anivovetmab
- anselamimab
- ansuvimab
- anumigilimab
- apamistamab
- aprutumab
- aprutumab ixadotin
- arcitumomab
- ascrinvacumab
- aselizumab
- astegolimab
- atezolizumab
- atibuclimab
- atidortoxumab
- atinumab
- atoltivimab
- atorolimumab
- avdoralimab
- avelumab
- avizakimab
- axatilimab
- azintuxizumab vedotin
- bafisontamab
- balstilimab
- bamlanivimab
- bapotulimab
- barecetamab
- barzolvolimab
- basiliximab
- basiliximab sarotalocan
- batoclimab
- bavituximab
- bavunalimab
- bebtelovimab
- bectumomab
- bedinvetmab
- befovacimab
- begelomab
- belantamab
- belantamab mafodotin
- belimumab
- beludavimab
- bemarituzumab
- benralizumab
- bentracimab
- benufutamab
- bepranemab
- berlimatoxumab
- bermekimab
- bersanlimab
- bertilimumab
- besilesomab
- betifisolimab
- bevacizumab
- bevacizumab beta
- bevacizumab gamma
- bexmarilimab
- bezlotoxumab
- bimekizumab
- birtamimab
- bivatuzumab
- bleselumab
- blinatumomab
- blontuvetmab
- bococizumab
- boserolimab
- botensilimab
- brazikumab
- brentuximab vedotin
- briakinumab
- briquilimab
- brodalumab
- brolucizumab
- brontictuzumab
- budigalimab
- burfiralimab
- cabiralizumab
- cadonilimab
- camidanlumab
- camidanlumab tesirine
- camoteskimab
- camrelizumab
- canakinumab
- cantuzumab mertansine
- cantuzumab ravtansine
- caplacizumab
- capromab
- carlumab
- carotuximab
- casirivimab
- catumaxomab
- cedelizumab
- cemiplimab
- cendakimab
- cergutuzumab amunaleukin
- certolizumab pegol
- cetrelimab
- cetuximab
- cetuximab sarotalocan
- cevostamab
- cibisatamab
- cifurtilimab
- cilgavimab
- cinpanemab
- cirevetmab
- citatuzumab bogatox
- cixutumumab
- clazakizumab
- clenoliximab
- clesrovimab
- clivatuzumab tetraxetan
- cobolimab
- codrituzumab
- cofetuzumab
- cofetuzumab pelidotin
- coltuximab ravtansine
- conatumumab
- concizumab
- coprelotamab
- cosibelimab
- crefmirlimab
- crefmirlimab berdoxam
- crenezumab
- crizanlizumab
- crotedumab
- crovalimab
- cudarolimab
- cusatuzumab
- dacetuzumab
- daclizumab
- daclizumab beta
- dafsolimab
- dafsolimab setaritox
- dalotuzumab
- dapirolizumab pegol
- daratumumab
- datopotamab
- datopotamab deruxtecan
- daxdilimab
- dectrekumab
- demcizumab
- demupitamab
- denintuzumab mafodotin
- denosumab
- depatuxizumab
- depatuxizumab mafodotin
- depemokimab
- derlotuximab biotin
- detumomab
- dinutuximab
- dinutuximab beta
- disitamab
- disitamab vedotin
- divozilimab
- docaravimab
- domvanalimab
- donanemab
- dorlimomab aritox
- dostarlimab
- dovanvetmab
- dresbuxelimab
- drozitumab
- duligotuzumab
- dupilumab
- durvalumab
- dusigitumab
- duvortuxizumab
- ebdarokimab
- eblasakimab
- ebronucimab
- ecleralimab
- ecromeximab
- eculizumab
- edrecolomab
- efalizumab
- eldelumab
- elezanumab
- elgemtumab
- elipovimab
- elotuzumab
- elranatamab
- elsilimomab
- emactuzumab
- emapalumab
- emerfetamab
- emfizatamab
- emibetuzumab
- emicizumab
- emirodatamab
- enapotamab
- enapotamab vedotin
- enavatuzumab
- encelimab
- enfortumab vedotin
- enibarcimab
- enlimomab
- enlimomab pegol
- enoblituzumab
- enokizumab
- enoticumab
- ensituximab
- enuzovimab
- envafolimab
- epcoritamab
- epitumomab
- epitumomab cituxetan
- epratuzumab
- eptinezumab
- erenumab
- erfonrilimab
- erlizumab
- ertumaxomab
- etaracizumab
- etesevimab
- etevritamab
- etigilimab
- etokimab
- etrolizumab
- evinacumab
- evolocumab
- exbivirumab
- exidavnemab
- ezabenlimab
- fanolesomab
- faralimomab
- faricimab
- farletuzumab
- farletuzumab ecteribulin
- fasinumab
- favezelimab
- fazpilodemab
- felzartamab
- fezakinumab
- fianlimab
- ficlatuzumab
- fidasintamab
- figitumumab
- finotolimab
- firivumab
- fiztasovimab
- fladilimab
- flanvotumab
- fletikumab
- flotetuzumab
- fontolizumab
- foralumab
- foravirumab
- fremanezumab
- fresolimumab
- frexalimab
- frovocimab
- frunevetmab
- fulranumab
- futuximab
- galcanezumab
- galegenimab
- galiximab
- gancotamab
- ganitumab
- gantenerumab
- garadacimab
- garivulimab
- gatipotuzumab
- gavilimomab
- gedivumab
- gefurulimab
- gemtuzumab
- gemtuzumab ozogamicin
- geptanolimab
- gevokizumab
- gilvetmab
- gimsilumab
- ginisortamab
- girentuximab
- girolalimab
- glembatumumab
- glembatumumab vedotin
- glenzocimab
- glofitamab
- golimumab
- golocdacimab
- gontivimab
- gosuranemab
- gratalimab
- gremubamab
- grisnilimab setaritox
- gumokimab
- guselkumab
- ianalumab
- ibalizumab
- ibritumomab tiuxetan
- icrucumab
- idactamab
- idarucizumab
- ieramilimab
- ifabotuzumab
- ifinatamab
- ifinatamab deruxtecan
- igovomab
- iladatuzumab
- iladatuzumab vedotin
- imalumab
- imaprelimab
- imciromab
- imdevimab
- imgatuzumab
- imsidolimab
- imvotamab
- inclacumab
- indatuximab ravtansine
- indusatumab
- indusatumab vedotin
- inebilizumab
- inezetamab
- infliximab
- inolimomab
- inotuzumab ozogamicin
- intetumumab
- iparomlimab
- ipilimumab
- iratumumab
- isatuximab
- iscalimab
- ispectamab debotansine
- istiratumab
- itepekimab
- itolizumab
- ivicentamab
- ivonescimab
- ivuxolimab
- ixekizumab
- izalontamab
- izenivetmab
- izuralimab
- keliximab
- labetuzumab
- labetuzumab govitecan
- lacnotuzumab
- lacutamab
- ladintrevimab
- ladiratuzumab
- ladiratuzumab vedotin
- lampalizumab
- lanadelumab
- landogrozumab
- laprituximab
- laprituximab emtansine
- larcaviximab
- latozinemab
- lebrikizumab
- lecanemab
- lemalesomab
- lemzoparlimab
- lenvervimab
- lenzilumab
- lerdelimumab
- leronlimab
- lesabelimab
- lesofavumab
- letaplimab
- letolizumab
- levilimab
- lexatumumab
- libivirumab
- licaminlimab
- lifastuzumab vedotin
- ligelizumab
- ligufalimab
- lilotomab
- lilotomab satetraxetan
- lintuzumab
- lintuzumab satetraxetan
- linvoseltamab
- lirentelimab
- lirilumab
- litifilimab
- livmoniplimab
- lodapolimab
- lodelcizumab
- lokivetmab
- lomtegovimab
- loncastuximab
- loncastuximab tesirine
- lonigutamab
- lonigutamab ugodotin
- lorigerlimab
- lorvotuzumab mertansine
- losatuxizumab
- losatuxizumab vedotin
- lucatumumab
- lulizumab pegol
- lumiliximab
- lumretuzumab
- lupartumab
- lupartumab amadotin
- lusvertikimab
- lutikizumab
- luveltamab
- luveltamab tazevibulin
- maftivimab
- magrolimab
- manelimab
- manfidokimab
- mapatumumab
- margetuximab
- marstacimab
- maslimomab
- matuzumab
- mavrilimumab
- mazorelvimab
- mecbotamab
- melrilimab
- mepolizumab
- metelimumab
- mezagitamab
- mibavademab
- milatuzumab
- minretumomab
- mipasetamab
- mipasetamab uzoptirine
- miptenalimab
- mirikizumab
- miromavimab
- mirvetuximab
- mirvetuximab soravtansine
- mirzotamab
- mirzotamab clezutoclax
- mitazalimab
- mitumomab
- modotuximab
- mogamulizumab
- monalizumab
- morolimumab
- mosunetuzumab
- motavizumab
- moxetumomab pasudotox
- mupadolimab
- murlentamab
- nacolomab tafenatox
- nadecnemab
- nadunolimab
- namilumab
- naptumomab estafenatox
- naratuximab
- naratuximab emtansine
- narnatumab
- narsoplimab
- natalizumab
- navivumab
- naxitamab
- necitumumab
- nemolizumab
- nerelimomab
- nesvacumab
- netakimab
- nimacimab
- nimotuzumab
- nipocalimab
- nirsevimab
- nivatrotamab
- nivolumab
- nofazinlimab
- nofetumomab merpentan
- nurulimab
- obexelimab
- obinutuzumab
- ocaratuzumab
- ociperlimab
- ocrelizumab
- odesivimab
- odulimomab
- ofatumumab
- olaratumab
- oleclumab
- olendalizumab
- olinvacimab
- olokizumab
- omalizumab
- omburtamab
- omodenbamab
- onartuzumab
- ongericimab
- ontamalimab
- ontuxizumab
- onvatilimab
- opicinumab
- oportuzumab monatox
- opucolimab
- ordesekimab
- oregovomab
- orilanolimab
- ormutivimab
- orticumab
- osemitamab
- osocimab
- otilimab
- otlertuzumab
- oxelumab
- ozanezumab
- ozoralizumab
- ozuriftamab
- ozuriftamab vedotin
- pacanalotamab
- pacmilimab
- palivizumab
- pamrevlumab
- panitumumab
- panobacumab
- parsatuzumab
- pascolizumab
- pasotuxizumab
- pateclizumab
- patritumab
- patritumab deruxtecan
- pavurutamab
- pelgifatamab
- pelgifatamab corixetan
- pembrolizumab
- penpulimab
- pepinemab
- perakizumab
- peresolimab
- pertuzumab
- pertuzumab zuvotolimod
- pexelizumab
- pidilizumab
- pimivalimab
- pimurutamab
- pinatuzumab vedotin
- pintumomab
- pivekimab
- pivekimab sunirine
- placulumab
- plonmarlimab
- plozalizumab
- plutavimab
- polatuzumab vedotin
- ponezumab
- porgaviximab
- posdinemab
- pozelimab
- praluzatamab ravtansine
- prasinezumab
- prezalumab
- priliximab
- pritoxaximab
- pritumumab
- prolgolimab
- pucotenlimab
- pulocimab
- quavonlimab
- quetmolimab
- quilizumab
- quisovalimab
- racotumomab
- radretumab
- rafivirumab
- ragifilimab
- ralpancizumab
- ramucirumab
- ranevetmab
- ranibizumab
- ravagalimab
- ravulizumab
- raxibacumab
- recaticimab
- refanezumab
- regavirumab
- regdanvimab
- relatlimab
- relfovetmab
- remtolumab
- reosalimab
- reslizumab
- retifanlimab
- revdofilimab
- rilotumumab
- rimteravimab
- rinucumab
- ripertamab
- risankizumab
- rituximab
- rivabazumab pegol
- robatumumab
- rocatinlimab
- roledumab
- rolinsatamab
- rolinsatamab talirine
- romilkimab
- romlusevimab
- romosozumab
- rontalizumab
- rosmantuzumab
- rosnilimab
- rosopatamab
- rosopatamab tetraxetan
- rovalpituzumab
- rovalpituzumab tesirine
- rovelizumab
- rozanolixizumab
- rulonilimab
- runimotamab
- ruplizumab
- sabatolimab
- sacituzumab
- sacituzumab govitecan
- samalizumab
- samrotamab
- samrotamab vedotin
- sarilumab
- sasanlimab
- satralizumab
- satumomab
- secukinumab
- selicrelumab
- semorinemab
- semzuvolimab
- serclutamab
- serclutamab salirine
- seribantumab
- serplulimab
- setoxaximab
- setrusumab
- sevirumab
- sibeprenlimab
- sibrotuzumab
- sifalimumab
- siltuximab
- simridarlimab
- simtuzumab
- sintilimab
- siplizumab
- sirexatamab
- sirtratumab
- sirtratumab vedotin
- sirukumab
- socazolimab
- sofituzumab vedotin
- solanezumab
- solitomab
- sonelokimab
- sontuzumab
- sotevtamab
- sotigalimab
- sotrovimab
- spartalizumab
- spesolimab
- stamulumab
- suciraslimab
- sudubrilimab
- sugemalimab
- sulesomab
- suptavumab
- surzebiclimab
- suvizumab
- suvratoxumab
- tabalumab
- tabituximab
- tabituximab barzuxetan
- tadocizumab
- tafasitamab
- tafolecimab
- tagitanlimab
- talacotuzumab
- talizumab
- talquetamab
- tamgiblimab
- tamrintamab
- tamrintamab pamozirine
- tamtuvetmab
- tanezumab
- taplitumomab paptox
- tarcocimab
- tarcocimab tedromer
- tarextumab
- tarlatamab
- tavolimab
- tebotelimab
- tecaginlimab
- teclistamab
- tefibazumab
- telazorlimab
- telimomab aritox
- telisotuzumab
- telisotuzumab vedotin
- temelimab
- tenatumomab
- teneliximab
- teplizumab
- tepoditamab
- teprotumumab
- teropavimab
- tesidolumab
- tesnatilimab
- tezepelumab
- tibulizumab
- tidutamab
- tifcemalimab
- tigatuzumab
- tilavonemab
- tildrakizumab
- tilogotamab
- tilvestamab
- timigutuzumab
- timolumab
- tinurilimab
- tiragolumab
- tirnovetmab
- tislelizumab
- tisotumab
- tisotumab vedotin
- tixagevimab
- tocilizumab
- tomaralimab
- tomuzotuximab
- toralizumab
- toripalimab
- torudokimab
- tosatoxumab
- tositumomab
- tovetumab
- tozorakimab
- tralokinumab
- trastuzumab
- trastuzumab beta
- trastuzumab botidotin
- trastuzumab corixetan
- trastuzumab deruxtecan
- trastuzumab duocarmazine
- trastuzumab emtansine
- trastuzumab imbotolimod
- trastuzumab rezetecan
- trastuzumab vedotin
- tregalizumab
- tremelimumab
- trevogrumab
- trinbelimab
- trontinemab
- tucotuzumab celmoleukin
- tusamitamab
- tusamitamab ravtansine
- tuvirumab
- tuvonralimab
- ubamatamab
- ublituximab
- ulenistamab
- uliledlimab
- ulocuplumab
- unasnemab
- upanovimab
- urabrelimab
- urelumab
- ustekinumab
- utomilumab
- vadastuximab
- vadastuximab talirine
- vandortuzumab vedotin
- vantictumab
- vanucizumab
- vapaliximab
- varisacumab
- varlilumab
- vatelizumab
- vedolizumab
- veltuzumab
- vepalimomab
- vepsitamab
- vesencumab
- vibecotamab
- vibostolimab
- vilobelimab
- visilizumab
- vixarelimab
- vixtimotamab
- vobarilizumab
- vobramitamab duocarmazine
- vofatamab
- volagidemab
- volociximab
- vonlerolizumab
- vopratelimab
- vorsetuzumab
- vorsetuzumab mafodotin
- votumumab
- voxalatamab
- vudalimab
- vulinacimab
- vunakizumab
- xeligekimab
- xentuzumab
- zagotenemab
- zalifrelimab
- zalutumumab
- zamerovimab
- zampilimab
- zanidatamab zovodotin
- zanolimumab
- zansecimab
- zelminemab
- zeluvalimab
- zenocutuzumab
- zilovertamab
- zilovertamab vedotin
- ziltivekimab
- zimberelimab
- zinlirvimab
- ziralimumab
- zolbetuximab
- zolimomab aritox
- zuberitamab
Decode another name
Decoded
atinumab
Listed INNCarries the WHO stem -mab
- -mabend of the nameWHO lists it hereWHO definition: monoclonal antibodies (previous naming scheme)
“atinumab” is an INN that WHO lists under -mab in the 2024 stem book.
The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.
Source and licence
The definition of -mab (Part II B) and the 831 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .
Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.